Isthmus Partners LLC grew its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 7.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 525,886 shares of the real estate investment trust's stock after acquiring an additional 36,357 shares during the period. Isthmus Partners LLC owned about 0.08% of Healthpeak Properties worth $10,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Mizuho Bank Ltd. bought a new stake in Healthpeak Properties during the fourth quarter valued at about $28,000. Harvest Fund Management Co. Ltd bought a new position in shares of Healthpeak Properties during the 4th quarter valued at approximately $30,000. Future Financial Wealth Managment LLC bought a new position in shares of Healthpeak Properties during the 1st quarter valued at approximately $30,000. S.A. Mason LLC increased its holdings in Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after acquiring an additional 925 shares in the last quarter. Finally, Covestor Ltd raised its stake in Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,152 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
DOC has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Robert W. Baird dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Wells Fargo & Company cut their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Scotiabank lowered their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Finally, Evercore ISI dropped their price objective on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $23.27.
View Our Latest Analysis on DOC
Insider Buying and Selling
In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,777 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director John T. Thomas purchased 4,200 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average price of $17.84 per share, with a total value of $74,928.00. Following the transaction, the director owned 813,566 shares of the company's stock, valued at $14,514,017.44. This represents a 0.52% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 29,764 shares of company stock worth $521,909. Insiders own 0.23% of the company's stock.
Healthpeak Properties Price Performance
Shares of DOC stock traded up $0.03 during trading hours on Wednesday, hitting $18.26. The stock had a trading volume of 4,948,593 shares, compared to its average volume of 5,360,873. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market capitalization of $12.69 billion, a price-to-earnings ratio of 45.65, a PEG ratio of 2.08 and a beta of 1.03. Healthpeak Properties, Inc. has a one year low of $16.64 and a one year high of $23.26. The stock's 50-day moving average price is $17.53 and its two-hundred day moving average price is $18.93.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The firm's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.45 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently declared a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be given a $0.1017 dividend. This represents a $1.22 annualized dividend and a yield of 6.68%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is presently 305.00%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.